VIP PASS for Patient Groups

 

22-24 September, 2026
RAI, Amsterdam

 

 

 

 

 

VIP Pass for Patient Groups

 
The patient voice is paramount to effective pharmacovigilance. A limited number of VIP passes are reserved for official representatives from verified Patient Advocacy Groups who contribute essential, real-world insights on drug safety and patient outcomes.
 
 
Eligibility Criteria for VIP Pass  
 
To qualify, you must be an official representative of a registered Patient Advocacy Group or Charity:
 
  • Chairs, Presidents, Directors, or official patient representatives of registered, non-commercial Patient Advocacy Groups or Charities.
 
  • Individuals whose primary, dedicated role involves representing patients in regulatory or scientific advisory discussions concerning drug safety.
 
  • The organisation must be a registered, non-commercial entity focusing solely on patient well-being and advocacy.
 
The WPSC is committed to supporting the vital presence of patient advocacy leaders at the congress, limited to the above eligibility criteria and capacity permitting. The WPSC reserves the right to withdraw this offer at any time, and this pass cannot be used to exchange or refund existing paid tickets. Colleagues representing different patient groups or local chapters must visit the standard registration page for their tickets.
 
Ready to claim your VIP pass?
 
APPLY FOR YOUR VIP PASS HERE

 

What your VIP pass includes:

Access to Conference Sessions: 23-24 September, 2026

Admission to the Exhibition

 

Get Involved At World Patient Safety Congress
 

Conference Production

George Mullens
george.mullens@terrapinn.com  
+44 20 8164 3940 

 

Sponsorship & Exhibition Sales

Grace Gowler
grace.gowler@terrapinn.com 
+44 20 3481 8981

  

Marketing Opportunities

Karolina Bzikot
karolina.bzikot@terrapinn.com